Thomas Knösel

7.9k total citations
176 papers, 4.3k citations indexed

About

Thomas Knösel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Thomas Knösel has authored 176 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 74 papers in Pulmonary and Respiratory Medicine and 46 papers in Surgery. Recurrent topics in Thomas Knösel's work include Sarcoma Diagnosis and Treatment (53 papers), Neuroendocrine Tumor Research Advances (21 papers) and Bone Tumor Diagnosis and Treatments (16 papers). Thomas Knösel is often cited by papers focused on Sarcoma Diagnosis and Treatment (53 papers), Neuroendocrine Tumor Research Advances (21 papers) and Bone Tumor Diagnosis and Treatments (16 papers). Thomas Knösel collaborates with scholars based in Germany, United States and Austria. Thomas Knösel's co-authors include Iver Petersen, A. Altendorf-Hofmann, Manfred Dietel, Glen Kristiansen, Karsten Schlüns, Hans Roland Dürr, Lars H. Lindner, Alexander Klein, Volkmar Jansson and Yuan Chen and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Thomas Knösel

165 papers receiving 4.3k citations

Peers

Countries citing papers authored by Thomas Knösel

Since Specialization

Citations

This map shows the geographic impact of Thomas Knösel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Knösel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Knösel more than expected).

Fields of papers citing papers by Thomas Knösel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Knösel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Knösel. The network helps show where Thomas Knösel may publish in the future.

Co-authorship network of co-authors of Thomas Knösel

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Knösel. A scholar is included among the top collaborators of Thomas Knösel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Knösel. Thomas Knösel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy 2025 ·Theranostics ·Friederike Herr, (unknown), R. Ebner, (unknown), Matthias P. Fabritius, Christine Schmid‐Tannwald, Mathias J. Zacherl, Vera Wenter, Lena M. Unterrainer, (unknown), Adrien Holzgreve, Rudolf A. Werner, Christoph J. Auernhammer, Christine Spitzweg, Thomas Knösel, (unknown), Jens Ricke, (unknown), (unknown), Clemens C. Cyran	0
2	Refusal of Adjuvant Therapies and Its Impact on Local Control and Survival in Patients with Bone and Soft Tissue Sarcomas of the Extremities and Trunk 2024 ·Cancers ·(unknown), Alexander Klein, Lars H. Lindner, Silke Birgit Nachbichler, Boris Michael Holzapfel, Markus Albertsmeier, Thomas Knösel, Hans Roland Dürr	0
3	Tissue-engineered patient-derived osteosarcoma models dissecting tumour-bone interactions 2024 ·Cancer and Metastasis Reviews ·(unknown), (unknown), Pervez Ahmed, Hans Roland Dürr, Alexander Klein, Thomas Knösel, (unknown), Jacqui McGovern, Dietmar W. Hutmacher, Boris Michael Holzapfel, Susanne Mayer‐Wagner	1
4	Unplanned Resections of Soft Tissue Sarcomas—Necessity of Re-Resection? 2024 ·Cancers ·(unknown), Alexander Klein, (unknown), Lars H. Lindner, Silke Birgit Nachbichler, Boris Michael Holzapfel, (unknown), Thomas Knösel, Hans Roland Dürr	3
5	Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), Philipp Lange, Dorit Di Gioia, M. Schmidt, Thomas Knösel, Frederick Klauschen, Michael von Bergwelt‐Baildon, Volker Heinemann, Philipp A. Greif, C. Benedikt Westphalen, Kathrin Heinrich, Lars H. Lindner	3
6	Colitis induced by IL-17A-inhibitors 2023 ·Clinical Journal of Gastroenterology ·(unknown), (unknown), Thomas Knösel, Alla Skapenko, Hendrik Schulze‐Koops	5
7	TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS) 2023 ·Cancers ·(unknown), A. Altendorf-Hofmann, Lars H. Lindner, (unknown), Dorit Di Gioia, Hans Roland Dürr, Alexander Klein, Markus Albertsmeier, Nina-Sophie Schmidt-Hegemann, Frederick Klauschen, Thomas Knösel	3
8	Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysis 2022 ·Pancreatology ·(unknown), Ujjwal Mukund Mahajan, Christoph J. Auernhammer, (unknown), (unknown), (unknown), Beata Kos‐Kudła, Marek Hartleb, Thomas Knösel, Jörg Schirra, Julia Mayerle, Christian Schulz, Michał Żorniak	1
9	Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144 2022 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Nina A. Hering, (unknown), Marco Arndt, Sefer Elezkurtaj, Thomas Knösel, Christiane J. Bruns, Georgios Antonios Margonis, Katharina Beyer, Hendrik Seeliger	7
10	Fatty Acid Receptor CD36 Functions as a Surrogate Parameter for Lymph Node Metastasis in Oral Squamous Cell Carcinoma 2021 ·Cancers ·Selgai Haidari, Matthias Tröltzsch, Thomas Knösel, Paris Liokatis, (unknown), (unknown), (unknown), Sven Otto, (unknown), (unknown), Florian Probst	17
11	Machine Learning–based Differentiation of Benign and Premalignant Colorectal Polyps Detected with CT Colonography in an Asymptomatic Screening Population: A Proof-of-Concept Study 2021 ·Radiology ·(unknown), Philipp Wesp, Anno Graser, Stefan Maurus, Christian Schulz, Thomas Knösel, Clemens C. Cyran, Jens Ricke, Michael Ingrisch, Philipp M. Kazmierczak	37
12	Relative Sensitivity of Core-Needle Biopsy and Incisional Biopsy in the Diagnosis of Musculoskeletal Sarcomas 2021 ·Cancers ·Alexander Klein, (unknown), Christof Birkenmaier, (unknown), Volkmar Jansson, Thomas Knösel, Hans Roland Dürr	16
13	Desmoglein-3 overexpression in oral squamous cell carcinoma is associated with metastasis formation and early recurrence: An immunohistochemical study 2021 ·Journal of Cranio-Maxillofacial Surgery ·Matthias Troeltzsch, (unknown), Selgai Haidari, Markus Troeltzsch, Sven Otto, Michael Ehrenfeld, Florian Probst, Thomas Knösel	9
14	Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based Chemotherapy 2021 ·Cancers ·(unknown), A. Altendorf-Hofmann, Hans Roland Dürr, Alexander Klein, Martin K. Angele, Markus Albertsmeier, Nina-Sophie Schmidt-Hegemann, Dorit Di Gioia, Thomas Knösel, Lars H. Lindner	9
15	Diagnostic Value of CEUS Prompting Liver Biopsy: Histopathological Correlation of Hepatic Lesions with Ambiguous Imaging Characteristics 2020 ·Diagnostics ·Thomas Geyer, Dirk‐André Clevert, (unknown), Paul Reidler, Sebastian Gassenmaier, Thomas Knösel, Johannes Rübenthaler, Vincent Schwarze, Marco Armbruster	6
16	Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma 2018 ·BMC Cancer ·Hendrik Seeliger, (unknown), Gerald Assmann, Yue Zhao, (unknown), Thomas Knösel, Martin E. Kreis, Christiane J. Bruns	19
17	Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma 2018 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Thomas Knösel, Yue Zhao, Gerald Assmann, Iraklis Pozios, (unknown), Christiane J. Bruns, Martin E. Kreis, Hendrik Seeliger	13
18	Is There Evidence for the Presence and Relevance of the PD-1/PD-L1 Pathway in Oral Squamous Cell Carcinoma? Hints From an Immunohistochemical Study 2016 ·Journal of Oral and Maxillofacial Surgery ·Matthias Troeltzsch, Timothy J. Woodlock, (unknown), Sven Otto, Markus Troeltzsch, Michael Ehrenfeld, Thomas Knösel	32
19	Novel Jet-Injection Technology for Nonviral Intratumoral Gene Transfer in Patients with Melanoma and Breast Cancer 2008 ·Clinical Cancer Research ·Wolfgang Walther, Robert Siegel, Dennis Kobelt, Thomas Knösel, Manfred Dietel, A. Bembenek, Jutta Aumann, Martin Schleef, (unknown), Ulrike Stein, Peter M. Schlag	39
20	Overexpression of c-erbB-2 protein correlates with chromosomal gain at the c-erbB-2 locus and patient survival in advanced colorectal carcinomas 2002 ·Clinical & Experimental Metastasis ·Thomas Knösel, (unknown), Ulrike Stein, Holger Schwabe, Karsten Schlüns, Peter M. Schlag, Manfred Dietel, Iver Petersen	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact